Comparison of Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention in Patients with Diabetes
详细信息 查看全文
- 作者：Bora Toklu MD (1)
Sripal Bangalore MD ; MHA ; FACC ; FAHA ; FSCAI (1) (2)
1. New York University School of Medicine ; New York ; NY ; 10016 ; USA
2. Cardiac Catheterization Laboratory ; Cardiovascular Clinical Research Center ; The Leon H. Charney Division of Cardiology ; New York University School of Medicine ; New York ; NY ; 10016 ; USA - 关键词：Coronary artery bypass graft ; Coronary artery disease ; Diabetes mellitus ; Drug ; eluting stents
- 刊名：Current Treatment Options in Cardiovascular Medicine
- 出版年：2015
- 出版时间：May 2015
- 年：2015
- 卷：17
- 期：5
- 全文大小：1,508 KB
- 参考文献：1. Abdallah, MS, Wang, K, Magnuson, EA (2013) Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. JAMA 310: pp. 1581-90 CrossRef
2. Windecker, S, Kolh, P (2014) ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35: pp. 2541-619 CrossRef
3. Bangalore, S, Kumar, S, Fusaro, M (2012) Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ 345: pp. e5170 CrossRef
4. Bangalore, S, Toklu, B, Amoroso, N (2013) Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ 347: pp. f6625 CrossRef
5. Bangalore, S, Toklu, B, Feit, F (2014) Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap? Circulation. Cardiovasc Interv 7: pp. 518-525 CrossRef
6. Banning, AP, Westaby, S, Morice, MC (2010) Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol 55: pp. 1067-75 CrossRef
7. Bayes-Genis, A, Conover, CA, Schwartz, RS (2000) The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86: pp. 125-30 CrossRef
8. Beatt KJ, Diabetes, multivessel and LMS disease: treating the whole patient. Transcatheter Cardiovascular Therapeutics 2012. Available from www.tctmd.com/ [December 2013]
9. Biondi-Zoccai, GG, Abbate, A, Liuzzo, G, Biasucci, LM (2003) Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol 41: pp. 1071-7 CrossRef
10. Booth, J, Clayton, T, Pepper, J (2008) Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 118: pp. 381-8 CrossRef
11. Brar, SS, Syros, G, Dangas, G (2008) Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications. Angiology 59: pp. 83S-8 CrossRef
First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet 346: pp. 1179-84 CrossRef
12. Cohen, DJ, Lavelle, TA, Hout, B (2012) Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter Cardiovasc Interv Off J Soc Cardiac Angiography Interv 79: pp. 198-209 CrossRef
13. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. (Mar 6 1993) Lancet 341(8845):573鈥?80
14. Daemen, J, Wenaweser, P, Tsuchida, K (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369: pp. 667-78 CrossRef
15. Danaei, G, Finucane, MM, Lu, Y (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378: pp. 31-40 CrossRef
16. Dangas, GD, Farkouh, ME, Sleeper, LA (2014) Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol 64: pp. 1189-97 CrossRef
17. Bruyne, B, Pijls, NH, Kalesan, B (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367: pp. 991-1001 CrossRef
18. Farkouh, ME, Domanski, M, Sleeper, LA (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367: pp. 2375-84 CrossRef
19. Fihn, SD, Blankenship, JC, Alexander, KP (2014) 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 130: pp. 1749-67 CrossRef
20. Fihn, SD, Gardin, JM, Abrams, J (2012) 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American college of cardiology foundation/American heart association task force on practice guidelines, and the American college of physicians, American association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 60: pp. e44-164 CrossRef
21. Group, BDS, Frye, RL, August, P (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360: pp. 2503-15 CrossRef
22. Haller, JD, Olearchyk, AS (2002) Cardiology鈥檚 10 greatest discoveries. Tex Heart Inst J/Tex Heart Inst St Luke鈥檚 Episcopal Hosp Tex Child Hosp 29: pp. 342-344
23. Hannan, EL, Racz, MJ, McCallister, BD (1999) A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 33: pp. 63-72 CrossRef
24. Hannan, EL, Racz, MJ, Walford, G (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352: pp. 2174-83 CrossRef
25. Hannan, EL, Wu, C, Walford, G (2008) Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358: pp. 331-41 CrossRef
26. Henderson, RA, Pocock, SJ, Sharp, SJ (1998) Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet 352: pp. 1419-25 CrossRef
27. Hillis, LD, Smith, PK, Anderson, JL (2012) 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 143: pp. 4-34 CrossRef
28. Hlatky, MA, Boothroyd, DB, Melsop, KA (2004) Medical costs and quality of life 10 to 12聽years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation 110: pp. 1960-6 CrossRef
29. Investigators, B (2007) The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol 49: pp. 1600-6 CrossRef
30. Kamalesh, M, Sharp, TG, Tang, XC (2013) Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes. J Am Coll Cardiol 61: pp. 808-16 CrossRef
31. Kappetein, AP, Head, SJ, Morice, MC (2013) Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 43: pp. 1006-13 CrossRef
32. Kapur, A, Hall, RJ, Malik, IS (2010) Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol 55: pp. 432-40 CrossRef
33. King, SB, Kosinski, AS, Guyton, RA, Lembo, NJ, Weintraub, WS (2000) Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 35: pp. 1116-21 CrossRef
34. King, SB, Lembo, NJ, Weintraub, WS (1994) A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 331: pp. 1044-50 CrossRef
35. Kip, KE, Faxon, DP, Detre, KM, Yeh, W, Kelsey, SF, Currier, JW (1996) Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94: pp. 1818-25 CrossRef
36. Kurbaan, AS, Bowker, TJ, Ilsley, CD, Sigwart, U, Rickards, AF (2001) Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol 87: pp. 947-950 CrossRef
37. Leavitt, BJ, Sheppard, L, Maloney, C (2004) Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery. Circulation 110: pp. II41-4
38. Levine, GN, Bates, ER, Blankenship, JC (2011) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol 58: pp. e44-122 CrossRef
39. Lima, EG, Hueb, W, Garcia, RM (2013) Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial. Am Heart J 166: pp. 250-7 CrossRef
40. Magnuson, EA, Farkouh, ME, Fuster, V (2013) Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Circulation 127: pp. 820-31 CrossRef
41. Morrison, DA, Sethi, G, Sacks, J (2001) Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the department of veterans affairs cooperative study #385, the angina with extremely serious operative mortality evaluation (AWESOME). J Am Coll Cardiol 38: pp. 143-9 CrossRef
42. O鈥橤ara, PT, Kushner, FG, Ascheim, DD (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 127: pp. e362-425 CrossRef
43. Onuma, Y, Wykrzykowska, JJ, Garg, S (2011) 5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. JACC Cardiovasc Interv 4: pp. 317-23 CrossRef
44. Park, SJ, Kim, YH, Park, DW (2011) Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 364: pp. 1718-27 CrossRef
45. Pijls, NH, Fearon, WF, Tonino, PA (2010) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 56: pp. 177-84 CrossRef
46. Rodriguez, AE, Baldi, J, Fernandez Pereira, C (2005) Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46: pp. 582-8 CrossRef
47. Rodriguez, A, Bernardi, V, Navia, J (2001) Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol 37: pp. 51-8 CrossRef
48. Sarno, G, Lagerqvist, B, Frobert, O (2012) Lower risk of stent thrombosis and restenosis with unrestricted use of 鈥榥ew-generation鈥?drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 33: pp. 606-13 CrossRef
49. Sedlis, SP, Morrison, DA, Lorin, JD (2002) Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 40: pp. 1555-66 CrossRef
50. Serruys, PW, Jaegere, P, Kiemeneij, F (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent study group. N Engl J Med 331: pp. 489-95 CrossRef
51. Serruys, PW, Ong, AT, Herwerden, LA (2005) Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol 46: pp. 575-81 CrossRef
52. Serruys, PW, Unger, F, Sousa, JE (2001) Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344: pp. 1117-24 CrossRef
53. Shaw, JE, Sicree, RA, Zimmet, PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: pp. 4-14 CrossRef
54. Sianos, G, Morel, MA, Kappetein, AP (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention J EuroPCR Collaboration Work Group Interv Cardiol Eur Soc Cardiol 1: pp. 219-27
55. Simpfendorfer, C, Belardi, J, Bellamy, G, Galan, K, Franco, I, Hollman, J (1987) Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty. Am J Cardiol 59: pp. 267-9 CrossRef
56. So, SI (2002) Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360: pp. 965-70 CrossRef
57. Soares, PR, Hueb, WA, Lemos, PA (2006) Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the medicine, angioplasty, or surgery study (MASS II). Circulation 114: pp. I420-4
58. Tada, T, Kimura, T, Morimoto, T (2011) Comparison of three-year clinical outcomes after sirolimus-eluting stent implantation among insulin-treated diabetic, non-insulin-treated diabetic, and non-diabetic patients from j-Cypher registry. Am J Cardiol 107: pp. 1155-62 CrossRef
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335: pp. 217-225 CrossRef
59. Thourani, VH, Weintraub, WS, Stein, B (1999) Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg 67: pp. 1045-52 CrossRef
60. Toklu, B, Bangalore, S (2014) Choosing the right coronary stent in the modern era. Curr Cardiol Rep 16: pp. 469 CrossRef
61. Weintraub, WS, Mahoney, EM, Zhang, Z (2004) One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial. Heart 90: pp. 782-8 CrossRef
62. Weintraub, WS, Mauldin, PD, Becker, E, Kosinski, AS, King, SB (1995) A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the emory angioplasty versus surgery trial (EAST). Circulation 92: pp. 2831-2840 CrossRef
63. Weiss AJ, Elixhauser A (2006) Trends in operating room procedures in U.S. hospitals, 2001鈥?011: Statistical Brief #171. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD)
64. Wenaweser, P, Daemen, J, Zwahlen, M (2008) Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 52: pp. 1134-40 CrossRef
65. Whang, W, Bigger, JT (2000) Diabetes and outcomes of coronary artery bypass graft surgery in patients with severe left ventricular dysfunction: results from the CABG patch trial database. The CABG patch trial investigators and coordinators. J Am Coll Cardiol 36: pp. 1166-72 CrossRef
66. Writing Committee, M, Jneid, H, Anderson, JL (2012) 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 126: pp. 875-910 CrossRef - 刊物主题：Cardiology;
- 出版者：Springer US
- ISSN：1534-3189
文摘